Pamprin Multi-Symptom

Product NDC: 71687-3003
11-digit product format: 716873003
Labeler code: 71687
Product ID: 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form: TABLET
Route: ORAL
Labeler: Focus Consumer Healthcare, LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2016-06-01
Substance: PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength: 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-4	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-4	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Pamprin Multi-Symptom
Brand name suffix: Maximum Strength
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PYRILAMINE MALEATE	15 mg/1
PAMABROM	25 mg/1
ACETAMINOPHEN	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R35D29L3ZA	Internal UNII lookup
UA8U0KJM72	Internal UNII lookup
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1052637	Internal RxNorm lookup
1053852	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
60b3286d-5698-df50-e053-2991aa0afbe2	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
71687-3003-1	2025-04-14	Pamprin MultiSymptom
71687-3003-4	2025-04-14	Pamprin MultiSymptom
71687-3003-1	2025-01-30	Pamprin MultiSymptom
71687-3003-4	2025-01-30	Pamprin MultiSymptom

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	20 in 1 BOTTLE, PLASTIC	TABLET	20	5
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	40 in 1 BOTTLE, PLASTIC	TABLET	40	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71687-3003	PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC]	4	Current NDC, Legacy NDC, 4 package rows	20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 50 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ASPIRIN 325 MG EC	ASPIRIN	Reliable 1 Laboratories LLC	2ab8564f-f958-7512-e054-00144ff88e88	2025-01-15	Warnings	Exact identifier application number: M013
ACETAMINOPHEN 325 MG	ACETAMINOPHEN	Reliable 1 Laboratories LLC	25626b46-78f8-7226-e054-00144ff8d46c	2025-01-15	Warnings	Exact identifier application number: M013
Aspirin 81 mg	ASPIRIN	Reliable 1 Laboratories LLC	b247fe39-7f65-e502-e053-2a95a90a08f1	2025-01-15	Warnings	Exact identifier application number: M013
Pharbetol	ACETAMINOPHEN 500MG	Ulai Health LLC	e64ce7b1-4501-4b51-b012-1882ed153b42	2025-01-13	Warnings	Exact identifier application number: M013
Aspirin Regular Strength	ASPIRIN 325MG	Ulai Health LLC	26942d32-d6e6-464d-8fc4-ffd9806d3e62	2025-01-12	Warnings	Exact identifier application number: M013
ACETAMINOPHEN	ACETAMINOPHEN	WAL-MART STORES INC	a354b24e-0913-829f-e053-2995a90ad407	2025-01-11	Warnings	Exact identifier application number: M013
ACETAMINOPHEN	ACETAMINOPHEN	WAL-MART STORES INC	8f221fdb-8138-c1a8-e053-2995a90a29c2	2025-01-11	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	A-S Medication Solutions	3294ba24-f198-485e-88fc-435964434b80	2025-01-09	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Major Pharmaceuticals	32ea1230-f9ae-46b0-910e-05cd187cee34	2025-01-09	Warnings	Exact identifier application number: M013
ACETAMINOPHEN 500 MG	ACETAMINOPHEN	Pioneer Life Sciences, LLC	e817bc4a-43ef-4126-b903-aabd1390cd0c	2025-01-08	Warnings	Exact identifier application number: M013
GeriCare Liquid Pain Relief	ACETAMINOPHEN	Geri-Care Pharmaceuticals, Corp	85a074da-14b7-4db5-9d47-8ad19f520721	2025-01-06	Warnings	Exact identifier application number: M013
Aspirin 81 mg Low Dose	ASPIRIN	Meijer Distribution Inc	eb29d6be-f095-44b2-b6ed-7e4167b596f8	2025-01-02	Warnings	Exact identifier application number: M013
Headache, Circle K	ACETAMINOPHEN, CAFFEINE, ASPIRIN TABLET	Lil' Drug Store Products, Inc.	e711ff0a-2fa0-1f2a-e053-2a95a90a4e38	2024-12-31	Warnings	Exact identifier application number: M013
Extra Strength Headache, Lil Drug Store	EXTRA STRENGHT HEADACHE RELIEF- ACETAMINOPHEN, ASPIRIN, CAFFEINE TABLET	Lil' Drug Store Products, Inc.	0c41deda-490b-f5d2-e063-6394a90a5047	2024-12-31	Warnings	Exact identifier application number: M013
Extra Strength Headache, Circle K	ACETAMINOPHEN/ASPIRIN/CAFFEINE TABLET	Lil' Drug Store Products, Inc.	d18e1631-de43-4b29-e053-2995a90af56d	2024-12-31	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN 500 MG, FILM-COATED TABLET	Lil' Drug Store Products, Inc.	e5f9def4-4cf5-4e06-e053-2995a90a07ea	2024-12-31	Warnings	Exact identifier application number: M013
Regular Strength Pain Relief	ACETAMINOPHEN	Geri-Care Pharmaceutical Corp	6158e954-32d8-4718-e053-2a91aa0a27f3	2024-12-31	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Advanced Rx Pharmacy of Tennessee, LLC	f8375029-e567-c6a5-e053-6394a90a5b67	2024-12-31	Warnings	Exact identifier application number: M013
Extra Strength Headache Relief	ACETAMINOPHEN, ASPIRIN, AND CAFFEINE	Dollar General	4907056d-6013-46b1-ae86-469dc3001591	2024-12-31	Warnings	Exact identifier application number: M013
Pediacare Childrens Grape	ACETAMINOPHEN	RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH	f9d531a2-234c-4feb-8f05-212dbee83dfe	2024-12-30	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R35D29L3ZA	PYRILAMINE MALEATE	59-33-6	PYRILAMINE MALEATE
UA8U0KJM72	PAMABROM	606-04-2	PAMABROM
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Max Strength Multi-Symptom 500 MG / 25 MG / 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SBD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SCD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	APAP 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Multi-Symptom (APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG) Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
71687-3003-1	71687300301	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current
71687-3003-4	71687300304	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current